Boulder, Colorado
United States
82
2024-04-25
The entities that hold a legal rights for patent applications filed by inventor Haas Julia:
Julia Haas from Boulder, US has applied for patents for these inventions. The list has both pending applications and granted patents:
METHOD OF TREATMENT USING SUBSTITUTED PYRAZOLO[1,5-A] PYRIMIDINE COMPOUNDS
#2 | 2024-02-29Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors
#3 | 2023-07-27METHOD OF TREATMENT USING SUBSTITUTED PYRAZOLO[1,5-A] PYRIMIDINE COMPOUNDS
#4 | 2023-03-23SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS
#5 | 2022-10-06Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors
#6 | 2022-04-21Substituted pyrazolo[1,5-A]pyrazine compounds as ret kinase inhibitors
#7 | 2021-06-24SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS
#8 | 2021-01-07Method of treatment using substituted pyrazolo[1,5-a] pyrimidine compounds
#9 | 2020-12-24Substituted pyrazolo[3,4-d]pyrimidines as RET kinase inhibitors
#10 | 2020-12-10Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors
#11 | 2020-10-29Substituted pyrrolo[2,3-d]pyrimidines compounds as ret kinase inhibitors
#12 | 2020-10-29Substituted pyrazolyl[4,3-c]pyridine compounds as RET kinase inhibitors
#13 | 2020-10-01KRAS G12C INHIBITORS
#14 | 2020-09-17MACROCYCLIC COMPOUNDS AS TRK KINASE INHIBITORS
#15 | 2020-08-20KRAS G12C INHIBITORS
#16 | 2020-07-09Process for the preparation of pyrazolo[1,5-a]pyrimidines and salts thereof
#17 | 2020-02-20Substituted pyrazolo[1,5-a]pyrazines as RET kinase inhibitors
#18 | 2020-01-30Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors
#19 | 2019-12-05Substituted pyrazolo[l,5-a]pyrimidine compounds as Trk kinase inhibitors
#20 | 2019-11-28PYRROLIDINYL UREA, PYRROLIDINYL THIOUREA AND PYRROLIDINYL GUANIDINE COMPOUNDS AS TRKA KINASE INHIBITORS
#21 | 2019-09-05Bicyclic urea, thiourea, guanidine and cyanoguanidine compounds useful for the treatment of pain
#22 | 2019-09-05KRas G12C inhibitors
#23 | 2019-08-29Crystalline forms
#24 | 2019-08-15FORMULATIONS OF A MACROCYCLIC TRK KINASE INHIBITOR
#25 | 2019-07-18Process for the preparation of (S)-N-(5-((R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)-pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide and salts thereof
#26 | 2019-07-11Method of treatment using substituted pyrazolo[1,5-A] pyrimidine compounds
#27 | 2019-06-20Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors
#28 | 2019-06-06Method of treatment using substituted imidazo[1,2b]pyridazine compounds
#29 | 2019-05-23Macrocyclic compounds as ROS1 kinase inhibitors
#30 | 2019-05-02SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS
#31 | 2019-05-02SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS
#32 | 2019-05-02SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS
#33 | 2019-03-14Macrocylic compounds as ROS1 kinase inhibitors
#34 | 2019-03-14MACROCYCLIC COMPOUNDS AS ROS1 KINASE INHIBITORS
#35 | 2019-01-31Macrocyclic compounds as TRK kinase inhibitors
#36 | 2018-11-22Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as TrkA kinase inhibitors
#37 | 2018-09-20Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitors
#38 | 2018-07-05Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors
#39 | 2018-07-05Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors
#40 | 2018-06-28Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors
#41 | 2018-05-31Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors
#42 | 2018-05-17Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors
#43 | 2018-05-17Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors
#44 | 2018-05-17Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors
#45 | 2018-05-17Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors
#46 | 2018-05-17Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors
#47 | 2018-05-10Method of treatment using substituted pyrazolo[1,5-a] pyrimidine compounds
#48 | 2017-10-05Macrocyclic compounds as TRK kinase inhibitors
#49 | 2017-08-03Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as TrkA kinase inhibitors
#50 | 2017-05-04Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitors
#51 | 2017-04-27Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitors
#52 | 2017-04-27Method of treatment using substituted imidazo[1,2b]pyridazine compounds
#53 | 2017-04-27Method of treatment using substituted pyrazolo[1,5-a] pyrimidine compounds
#54 | 2017-04-27Macrocyclic compounds as Trk kinase inhibitors
#55 | 2017-04-27Method of treatment using substituted imidazo[1,2b]pyridazine compounds
#56 | 2017-04-27Macrocyclic compounds as Trk kinase inhibitors
#57 | 2017-04-20Macrocyclic compounds as TRK kinase inhibitors
#58 | 2017-04-06Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors
#59 | 2016-12-08Bicyclic urea, thiourea, guanidine and cyanoguanidine compounds useful for the treatment of pain
#60 | 2016-10-13Pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors
#61 | 2016-09-22N-(arylalkyl)-Nā²-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors
#62 | 2016-09-01Method of treatment using substituted imidazo[1,2b]pyridazine compounds
#63 | 2016-08-11Method of treatment using substituted pyrazolo[1,5-A] pyrimidine compounds
#64 | 2015-11-26Macrocyclic compounds as trk kinase inhibitors
#65 | 2015-06-18Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as TrkA kinase inhibitors
#66 | 2015-05-14Method of treatment using substituted pyrazolo[1,5-a] pyrimidine compounds
#67 | 2015-01-29Substituted pyrazolo [1,5-A] pyrimidine compounds as TRK kinase inhibitors
#68 | 2015-01-01Method of treatment using substituted pyrazolo[1,5-a]pyrimidine compounds
#69 | 2014-07-10Method of treatment using substituted pyrazolo[1,5-a]pyrimidine compounds
#70 | 2013-08-22Method of treatment using substituted imidazo[1,2B]pyridazine compounds
#71 | 2013-08-08Macrocyclic compounds as Trk kinase inhibitors
#72 | 2012-05-03Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitors
#73 | 2011-08-11Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitors
#74 | 2011-07-07Substituted imidazo[1,2b]pyridazine compounds as Trk kinase inhibitors
#75 | 2010-04-29Cyclopropane compounds and pharmaceutical use thereof
#76 | 2009-04-16INHIBITORS OF VIRAL REPLICATION
#77 | 2009-04-09Compounds and methods for inhibiting hepatitis C viral replication
#78 | 2009-02-19NOVEL INHIBITORS OF HEPATITIS C VIRUS REPLICATION
#79 | 2008-12-11Cyclopropane compounds and pharmaceutical use thereof
#80 | 2008-10-02N-Substituted-N-Sulfonylaminocyclopropane Compounds and Pharmaceutical Use Thereof
#81 | 2006-09-07Cyclopropane compounds and pharmaceutical use thereof
#82 | 2005-10-06N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof
378625 ā